Gilder Gagnon Howe & Co’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-29
| Closed | – | – | 295 |
|
|
2021
Q4 | $0 | Hold |
29
| – | – | ﹤0.01% | 390 |
|
|
2021
Q3 | $1K | Hold |
29
| – | – | ﹤0.01% | 421 |
|
|
2021
Q2 | $1K | Hold |
29
| – | – | ﹤0.01% | 406 |
|
|
2021
Q1 | $1K | Sell |
29
-12
| -29% | -$414 | ﹤0.01% | 390 |
|
|
2020
Q4 | $1K | Sell |
41
-61,775
| -100% | -$1.51M | ﹤0.01% | 336 |
|
|
2020
Q3 | $2.33M | Sell |
61,816
-98,704
| -61% | -$3.72M | 0.01% | 233 |
|
|
2020
Q2 | $6.87M | Buy |
+160,520
| New | +$6.87M | 0.05% | 166 |
|
|
2020
Q1 | – | Sell |
-2,182
| Closed | -$57K | – | 281 |
|
|
2019
Q4 | $57K | Hold |
2,182
| – | – | ﹤0.01% | 275 |
|
|
2019
Q3 | $59K | Hold |
2,182
| – | – | ﹤0.01% | 271 |
|
|
2019
Q2 | $59K | Hold |
2,182
| – | – | ﹤0.01% | 278 |
|
|
2019
Q1 | $63K | Sell |
2,182
-41
| -2% | -$1.18K | ﹤0.01% | 263 |
|
|
2018
Q4 | $60K | Buy |
+2,223
| New | +$60K | ﹤0.01% | 256 |
|